Trials / Completed
CompletedNCT06951945
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity: A Randomized, Bouble-Blind, Placebo-Controlled Phase Ib Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Tonghua Dongbao Pharmaceutical Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with obesity. This study includes three multiple-ascending dose cohorts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | THDBH120 injection | Participants received THDBH120 by subcutaneous injection. |
| DRUG | Placebo of THDBH120 injection | Participants received placebo by subcutaneous injection. |
Timeline
- Start date
- 2024-07-18
- Primary completion
- 2024-12-23
- Completion
- 2024-12-23
- First posted
- 2025-04-30
- Last updated
- 2025-04-30
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06951945. Inclusion in this directory is not an endorsement.